FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...